Inventor
OLSEN OLE HVILSTED
DK36 patents
⚠️ This page may combine multiple inventors who share the name “OLSEN OLE HVILSTED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
21 patentsUS6262044B1Jul 17, 2001
Modulators of protein tyrosine phosphatases (PTPASES)
NOVO NORDISK AS108 citations97
US6197567B1Mar 6, 2001
Modified subtilisins and detergent compositions containing same
NOVO NORDISK AS108 citations97
US5665587ASep 9, 1997
Modified subtilisins and detergent compositions containing same
NOVO NORDISK AS146 citations97
US6410586B1Jun 25, 2002
Modulators of protein tyrosine phosphatases (PTPases)
NOVO NORDISK AS78 citations95
US5705482AJan 6, 1998
Pharmaceutical formulation
NOVO NORDISK AS70 citations95
US7019026B1Mar 28, 2006
Modulators of Protein Tyrosine Phosphatases (PTPases)
NOVO NORDISK AS23 citations91
US8361469B2Jan 29, 2013
Antibodies against tissue factor pathway inhibitor
NOVO NORDISK AS17 citations89
US5990084ANov 23, 1999
Compounds with growth hormone releasing properties
NOVO NORDISK AS44 citations89
US6410556B1Jun 25, 2002
Modulators of protein tyrosine phosphateses (PTPases)
NOVO NORDISK AS19 citations82
US5859010AJan 12, 1999
Factor VII -binding reagent
NOVO NORDISK AS17 citations82
US6951878B2Oct 4, 2005
Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
NOVO NORDISK AS7 citations73
US6613903B2Sep 2, 2003
Modulators of protein tyrosine phosphatases (PTPases)
NOVO NORDISK AS9 citations71
US6022858AFeb 8, 2000
Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
NOVO NORDISK AS11 citations70
US7419803B2Sep 2, 2008
Nucleic acids encoding human coagulation Factor VII polypeptides
NOVO NORDISK AS2 citations62
US7115624B1Oct 3, 2006
Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48
NOVO NORDISK AS6 citations61
US9371370B2Jun 21, 2016
Coagulation factor VII polypeptides
NOVO NORDISK AS2 citations60
US10906960B2Feb 2, 2021
Factor VIII variants having a decreased cellular uptake
NOVO NORDISK AS0 citations56
US9574011B2Feb 21, 2017
Antibodies against tissue factor pathway inhibitor
NOVO NORDISK AS0 citations49
US8652471B2Feb 18, 2014
Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitor
NOVO NORDISK AS0 citations49
US10047142B2Aug 14, 2018
Factor VIII variants having a decreased cellular uptake
NOVO NORDISK AS0 citations45
US9125890B2Sep 8, 2015
Compounds suitable for treatment of haemophilia
NOVO NORDISK AS0 citations40
NOVO NORDISK HEALTHCARE AG
9 patentsUS7026524B2Apr 11, 2006
Human coagulation factor VII variants
NOVO NORDISK HEALTHCARE AG59 citations96
US7176288B2Feb 13, 2007
Human coagulation factor VII variants
NOVO NORDISK HEALTHCARE AG29 citations92
US6960657B2Nov 1, 2005
Human coagulation factor VII polypeptides
NOVO NORDISK HEALTHCARE AG21 citations92
US6911323B2Jun 28, 2005
Human coagulation factor VII polypeptides
NOVO NORDISK HEALTHCARE AG31 citations92
US6905683B2Jun 14, 2005
Human coagulation factor VII variants
NOVO NORDISK HEALTHCARE AG15 citations92
US7416861B2Aug 26, 2008
Human coagulation factor VII polypeptides
NOVO NORDISK HEALTHCARE AG14 citations84
US7052868B2May 30, 2006
Human coagulation factor VII polypeptides
NOVO NORDISK HEALTHCARE AG9 citations73
US9370583B2Jun 21, 2016
Coagulation factor VII polypeptides
NOVO NORDISK HEALTHCARE AG4 citations69
US7695935B2Apr 13, 2010
Nucleic acids encoding human coagulation FVII polypeptides
NOVO NORDISK HEALTHCARE AG0 citations52